Jeffrey J Kraws insider trades

Open-market stock purchases and sales by Jeffrey J Kraws, Director at Theriva Biologics, Inc, from SEC Form 4 filings since Dec 22, 2009.

Recent trades

DateStockTradeValue
Jan 5, 2026TOVX Theriva Biologics, IncBought (not open market)—

Companies traded

  • TOVX Theriva Biologics, Inc: other filings, last Jan 5, 2026
  • SYN Synthetic Biologics, Inc: other filings, last Dec 23, 2021
  • RMED Ra Medical Systems, Inc: 2 buys, 2 sales, last Nov 20, 2020
  • SLNN Saleen Automotive, Inc: other filings, last Aug 12, 2014
  • AEN Adeona Pharmaceuticals, Inc: other filings, last Jan 5, 2011

Get free alerts when Jeffrey J Kraws files a new trade →